Otros idiomas BioForce Nanosciences Holdings, Inc.

Acciones

BFNH

US09064C2061

Diferido OTC Markets Otros sitios de cotización 21:42:12 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1,1 ^USD	-11,29 %		-23,61 %	-45,27 %

03/05	BioForce Nanosciences Holdings, Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
01/04	BioForce Nanosciences Holdings, Inc. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01/08/23
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09/05/23
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	28/03/23
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	28/03/23
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	02/11/22
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	02/11/22
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	27/07/22
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/07/22
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)	05/05/22
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	05/05/22
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/05/22
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	11/02/22
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	11/02/22
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	11/02/22
BIOFORCE NANOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	30/11/21
BioForce Nanosciences Holdings, Inc. Announces CEO Changes	30/11/21
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021	30/11/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas BioForce Nanosciences Holdings, Inc.

Acciones

BFNH

US09064C2061

Otros idiomas

Filtros